Rajeev Nema
Overview
Explore the profile of Rajeev Nema including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vats P, Nirmal S, Kumar A, Nema R
J Biomed Res
. 2025 Feb;
:1-4.
PMID: 39930665
No abstract available.
2.
Nema R
Rep Pract Oncol Radiother
. 2025 Jan;
29(5):649-650.
PMID: 39759552
Multi-omics approaches are revolutionizing cancer research and treatment by integrating single-modality omics methods, such as the transcriptome, genome, epigenome, epi-transcriptome, proteome, metabolome, and developing omics (single-cell omics). These technologies enable...
3.
Nema R, Vats P, Singh J, Srivastava S, Kumar A
Asian Pac J Cancer Prev
. 2024 Oct;
25(10):3673-3689.
PMID: 39471036
Objective: Lactate dehydrogenase is dysregulated in several cancer types. However, the mechanism of its dysregulation in lung cancer is not fully understood. We utilized web-based computational databases to conduct gene...
4.
Pateriya A, Nema R, Mishra A, Kumar A, Shrivastava A
Asian Pac J Cancer Prev
. 2024 Sep;
25(9):3187-3197.
PMID: 39342598
Objective: Triple negative breast cancer (TNBC) is an aggressive from of breast cancer and is associated with poor prognosis. Tumor microenvironment of breast cancer consists of a wide range of...
5.
Vats P, Singh J, Srivastava S, Kumar A, Nema R
Asian Pac J Cancer Prev
. 2024 Aug;
25(8):2929-2944.
PMID: 39205592
Background: Understanding the heterogeneous nature of breast cancer, including the role of LDHA expression regulation via non-coding RNAs in prognosis, is still unknown, highlighting the need for more research into...
6.
Tiwari S, Pandey R, Kumar V, Das S, Gupta V, Nema R, et al.
Noncoding RNA Res
. 2024 Aug;
9(4):1333-1341.
PMID: 39131689
The disease burden of Oral Squamous Cell Carcinoma (OSCC) is rising day-by-day and is expected to rise 62 % through 2035. The chewing of tobacco, areca nut, and betel leaf,...
7.
Nema R, Pandey R, Kumar A
Asian Pac J Cancer Prev
. 2024 Mar;
25(3):725-733.
PMID: 38546054
Objective: Availability of multimodal treatment strategies, including targeted therapies and immunotherapies, have improved the survival of non-small cell lung carcinoma (NSCLC). However, some patients still progress or respond poorly due...
8.
Singh A, Kant R, Raina R, Dhingra V, Nema R, Chand Bairwa M, et al.
Indian J Endocrinol Metab
. 2024 Mar;
28(1):35-42.
PMID: 38533281
Introduction: Gastrointestinal neuropathies are frequently found in diabetic patients. The pathogenesis of diabetic gastroparesis (DG) is multifactorial. The usual treatment for DG includes dietary modifications, prokinetic and antiemetic agents. There...
9.
Nema R, Saluja R, Kumar A
Front Immunol
. 2024 Jan;
15:1362881.
PMID: 38292872
No abstract available.
10.
Tiwari S, Pandey R, Kumar V, Das S, Gupta V, Vishwakarma S, et al.
Cancer Biomark
. 2023 Aug;
38(2):203-214.
PMID: 37545224
Background: miRNAs play a crucial role in the genesis of cancer, either as tumor suppressor genes or as oncogenes. Single Nucleotide Polymorphisms (SNPs) in the seed region of microRNAs (miRNAs)...